Atezolizumab

Atezolizumab
Trade Name
Orphan Indication Small cell lung cancer (SCLC)
USA Market Approval USA
USA Designation Date 2016-10-13 00:00:00
Sponsor Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080